preventing constipation on semaglutide and How to Manage It Semaglutide Constipation: Causes, Duration &

Results showed dose-dependent weight loss: the 0.25mg dose produced 4.5% additional weight loss beyond diet and placebo, the 0.5mg dose achieved 9.2% weight loss, and the 1.0mg dose resulted in 10.6% weight lossrepresenting approximately twice the efficacy of other approved obesity drugs available at that time

If a patient is on Fosamax and has difficulty maintaining upright sitting or standing for 30 minutes after morning medications due to their mobility limitations, this is a clinically relevant piece of information to discuss with them and, when appropriate, to flag with the medical team

There are several reasons behind this recommendation

Tirzepatide produced even greater results